The Leona M. and Harry B. Helmsley Charitable Trust has announced more than $2 million in grants to support medical research and healthcare in Israel. The grants to Tel Aviv University and the Jerusalem College of Technology come on the heels of more than $25 million granted by the Helmsley Charitable Trust to Israeli institutions in the past 12 months and are part of a continuing effort to strategically invest in furthering healthcare and research in Israel.
Since the Trust began awarding grants to Israel-related projects in 2010, it has committed more than $152 million to a wide range of charitable organizations in Israel.
“These latest grants support two of Israel’s important medical research and educational institutions. We are proud to continue our support of Tel Aviv University’s nanotechnology research. This innovative project aims to license technology for cancer, cardiovascular and IBD illnesses, either to major pharmaceutical or start-up companies, further enhancing Israel’s contributions to the well-being of the world,” said Helmsley trustee Sandor Frankel.
In addition, said Frankel, “The grant to the Jerusalem College of Technology for sophisticated laboratory facilities will ensure that nursing graduates are equipped to provide the highest level of health services throughout Israel for all of its citizens.”
Following is a description of the grants:
Tel Aviv University: Nanomedicines for Personalized Theranostics: Cancer, and Cardiovascular and Inflammatory Diseases
A grant of $1,800,000 over the next two years to Tel Aviv University will maximize the government matching available for basic and translational nanotechnology research at TAU, building on headway made over the last three years in developing drug-delivery systems and other platforms for therapy and diagnostics in cancer, and cardiovascular and inflammatory bowel diseases (IBD). This five-year project began in October, 2012, with support from the Helmsley Charitable Trust, to develop new disease management strategies using the medical application of nanotechnology, or “nanomedicine.” The ultimate goal is to translate fruitful strategies into the clinic, impacting the lives of millions of people suffering from such conditions around the world, and strengthening TAU and Israel as global leaders in the field.
Jerusalem College of Technology: Support for Nursing Simulation Laboratories
The Jerusalem College of Technology has been granted $244,750 to equip two simulation laboratories used for training 700 nursing students across two campuses. The equipment provided will be used both to upgrade an older existing simulation laboratory and to create a new lab on two of JCT’s women’s campuses. These high-tech facilities will provide professional training in areas such as anatomy, physiology, and communications. Comparable learning experiences in hospital or clinical settings present elements of risk, and include time pressures that can inhibit other aspects of clinical training. Students utilizing the laboratory employ all applicable disciplines and best practices, and receive reliable feedback using the lab’s digital resources.
About the Helmsley Charitable Trust
The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting effective nonprofits in health, place-based initiatives, and education and human services. Since 2008, when the Trust began its active grantmaking, it has committed more than $1.4 billion to a wide range of charitable organizations. The Trust’s grantmaking program in Israel supports leading institutions and initiatives that seek to strengthen the nation’s leadership in scientific, technological and medical research, its health care preparedness, and its standing in the world. For more information, please visit www.helmsleytrust.org.